180 results on '"Earnest, David L."'
Search Results
2. Dietary Fiber or Piroxicam as Potential Cancer Prevention Agents: Effects on Rectal Epithelial Cell Proliferation in Humans at Increased Risk of Colon Cancer
3. Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies
4. MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness
5. The Incidence of Abdominal and Pelvic Surgery Among Patients with Irritable Bowel Syndrome
6. Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients
7. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas
8. Tegaserod and the Risk of Cardiovascular Ischemic Events: An Observational Cohort Study
9. Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia: Results of Two Randomized, Controlled Trials
10. Safety, Tolerability, and Efficacy of Tegaserod over 13 Months in Patients with Chronic Constipation: CME
11. Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod
12. Tegaserod Does not Alter Fasting or Meal-Induced Biliary Tract Motility
13. The Zelnorm epidemiologic study (ZEST): a cohort study evaluating incidence of abdominal and pelvic surgery related to tegaserod treatment
14. Physical Activity, Body Mass Index, and Prostaglandin E2 Levels in Rectal Mucosa
15. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis
16. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome
17. Simultaneous quantitation of fatty acids, sterols and bile acids in human stool by capillary gas–liquid chromatography
18. Modulation of Kupffer cell and peripheral blood monocyte activity byin vivo treatment of rats with all-trans-retinol
19. Whose guidelines should you use?
20. Guidelines for Training in Gallstone Lithotripsy
21. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
22. The Duty of Arbitrators to Delimitate between Jurisdiction and Admissibility in Investor-State Arbitration: A Developed Consensus or an Enduring Lacuna?
23. Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint
24. Protective role of wheat bran fiber: data from marker trials
25. Progress report: the Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps
26. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
27. Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
28. Idiopathic cecal ulcer: Diagnosis by colonoscopy followed by nonoperative management
29. Unusual contrast accumulations seen during percutaneous cholangiography
30. Su1379 Using the FDA Composite Endpoint for IBS-D to Compare Treatment Effectiveness of Existing and Investigational Therapeutic Options
31. Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies
32. Geographic information systems can enhance economic development efforts at local and state levels
33. Cholescintigraphy in the evaluation of jaundice
34. Modulation of Kupffer cell and peripheral blood monocyte activity by in vivo treatment of rats with all-trans-retinol
35. Protective Effect of Tegaserod Against Indomethacin-Induced Gastric Injury in the Rat
36. Results of a Phase I Multiple-Dose Clinical Study of Ursodeoxycholic Acid
37. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms
38. Statement on outpatient percutaneous liver biopsy
39. Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
40. The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts
41. Antibiotic treatment prevents increased kupffer cell intracellular superoxide induced by acute alcohol ingestion
42. Suppression of cyclooxygenase does not have an early effect on rectal epithelial cell proliferation
43. A single alcohol binge significantly lowers the threshold for liver injury by acetaminophen and ischemia
44. Heartburn/stomach symptoms during chronic proton pump inhibitor therapy: Evidence for occasional symptom breakthrough
45. A convenient synthesis of dinorbile acids
46. Esophageal Hypersensitivity May Be A Major Cause of Heartburn
47. GASTRIC XANTHELASMA IN A PATIENT AFTER PARTIAL GASTRECTOMY
48. A Placebo-Controlled Dose-Ranging Study of Lansoprazole in the Management of Reflux Esophagitis
49. Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation
50. Review and Analysis of the Effects of Olestra, a Dietary Fat Substitute, on Gastrointestinal Function and Symptoms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.